Literature DB >> 25010054

Utility before business.

Steven M Teutsch1, Jonathan E Fielding2, Muin J Khoury3, James P Evans4.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25010054      PMCID： PMC4690454          DOI： 10.1038/gim.2014.71

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  9 in total

1.  Special report: exome sequencing for clinical diagnosis of patients with suspected genetic disorders.

Authors: 
Journal:  Technol Eval Cent Assess Program Exec Summ       Date:  2013-08

2.  A health dividend for America: the opportunity cost of excess medical expenditures.

Authors:  Jeffrey C McCullough; Frederick J Zimmerman; Jonathan E Fielding; Steven M Teutsch
Journal:  Am J Prev Med       Date:  2012-12       Impact factor: 5.043

3.  Clinical application of whole-genome sequencing: proceed with care.

Authors:  William Gregory Feero
Journal:  JAMA       Date:  2014-03-12       Impact factor: 56.272

Review 4.  Prioritizing genomic applications for action by level of evidence: a horizon-scanning method.

Authors:  W D Dotson; M P Douglas; K Kolor; A C Stewart; M S Bowen; M Gwinn; A Wulf; H M Anders; C Q Chang; M Clyne; T K Lam; S D Schully; M Marrone; W G Feero; M J Khoury
Journal:  Clin Pharmacol Ther       Date:  2014-02-19       Impact factor: 6.875

5.  Outcomes of interest in evidence-based evaluations of genetic tests.

Authors:  Jeffrey R Botkin; Steven M Teutsch; Celia I Kaye; Maxine Hayes; James E Haddow; Linda A Bradley; Kathleen Szegda; W David Dotson
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

6.  Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility.

Authors:  Scott D Grosse
Journal:  Genet Med       Date:  2013-10-10       Impact factor: 8.822

7.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.

Authors:  Robert C Green; Jonathan S Berg; Wayne W Grody; Sarah S Kalia; Bruce R Korf; Christa L Martin; Amy L McGuire; Robert L Nussbaum; Julianne M O'Daniel; Kelly E Ormond; Heidi L Rehm; Michael S Watson; Marc S Williams; Leslie G Biesecker
Journal:  Genet Med       Date:  2013-06-20       Impact factor: 8.822

8.  The arrival of genomic medicine to the clinic is only the beginning of the journey.

Authors:  James P Evans; Muin J Khoury
Journal:  Genet Med       Date:  2013-01-10       Impact factor: 8.822

9.  The business of genomic testing: a survey of early adopters.

Authors:  James M Crawford; Lynn Bry; John Pfeifer; Samuel K Caughron; Stephen Black-Schaffer; Jeffrey A Kant; Jill H Kaufman
Journal:  Genet Med       Date:  2014-07-10       Impact factor: 8.822
  9 in total
  1 in total

Review 1.  Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors.

Authors:  Rita K Schmutzler; Björn Schmitz-Luhn; Bettina Borisch; Peter Devilee; Diana Eccles; Per Hall; Judith Balmaña; Stefania Boccia; Peter Dabrock; Günter Emons; Wolfgang Gaissmaier; Jacek Gronwald; Stefanie Houwaart; Stefan Huster; Karin Kast; Alexander Katalinic; Sabine C Linn; Sowmiya Moorthie; Paul Pharoah; Kerstin Rhiem; Tade Spranger; Dominique Stoppa-Lyonnet; Johannes Jozef Marten van Delden; Marc van den Bulcke; Christiane Woopen
Journal:  Breast Care (Basel)       Date:  2021-08-12       Impact factor: 2.268
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.